Recognify Life Sciences
2 clinical trials · Sponsor
◉ Watch Recognify Life Sciences
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) (NCT05686239) | Recognify Life Sciences | 2022-12-08 |
| Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia (NCT04822883) | Recognify Life Sciences | 2021-04-26 |
Track Recognify Life Sciences automatically
Every clearance here is in the API, with alerts when new ones post.